Compare INNIO N.V. Ordinary Shares (INIO) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
INNIO N.V. Ordinary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? INNIO N.V. Ordinary Shares trades at $16.44 (market cap $13.73B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: INNIO N.V. Ordinary Shares is far larger — about 7.6× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, INNIO N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold INNIO N.V. Ordinary Shares for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| INIO | VIR | |
|---|---|---|
Market Cap | $13.73B | $1.80B |
Volume | 5,012,195 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $41.13 | $11.78 |
52-Week Low | $16.50 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $15.39B | $1.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About INNIO N.V. Ordinary Shares
INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
